Pharma Published on March 5, 2020 Merck is launching a new public awareness campaign for cancer immunotherapy, a type of treatment that uses the immune system to fight cancer1. 1 The “Redefining Cancer Treatment” campaign aims to raise awareness and provide information to Quebecers and Canadians about cancer immunotherapy by presenting the stories of four patients from different parts of the country and their journey. Read more on News Wire
Business environment Published on March 5, 2020 Canadian female founders take on Silicon Valley with BDC and TCS. These founders represented 12 Canadian tech companies who just returned to Canada after attending the 2020 Women in Tech Silicon Valley Program. Read more on News Wire
Business environment Published on March 5, 2020 Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts. Read more on News Wire
R&D Published on March 5, 2020 Canadians at the forefront of VIDOC-19 research. The risk of a global pandemic has put scientists in Quebec and Canada at the forefront of the global response to the new coronavirus outbreak, according to several prominent researchers. Read more on La Presse
R&D Published on March 5, 2020 Novartis receives Health Canada approval for Mayzent™ (siponimod) to treat secondary progressive multiple sclerosis with active disease. Read more on News Wire
Business environment Published on March 5, 2020 Change to Theratechnologies Management Team: Appointment of Paul Lévesque as the company’s President and CEO, replacing Luc Tanguay, who is retiring after a 23-year career. Read more on News Wire
Artificial Intelligence Published on March 5, 2020 Artificial intelligence against cancer: discover five promising Quebec AI research projects that have just been funded by a competition called Onco-Tech. Read more on La Presse
Pharma Published on March 5, 2020 Valeo Pharma Reports 2019 Financial Results and Closing of $2.1 Million Private Placement Read more on News Wire
R&D Published on March 4, 2020 The Government of Canada is investing in regenerative medicine research to support the health of Canadians: $6.9 million in research funding supporting some of the most promising stem cell research in the country. Read more on News Wire